Clinical Trials

Home  >  Pipeline  >  Clinical Trials
Vivacity-MG

Nipocalimab, an anti-FcRn antibody, in adult patients with generalized myasthenia gravis (gMG)

Learn more

Unity

Nipocalimab, an anti-FcRn antibody, in women who are currently pregnant and have had a prior pregnancy with hemolytic disease of the fetus and newborn (HDFN).

Learn more

Energy Study

Nipocalimab, an anti-FcRn antibody, in adult patients with warm autoimmune hemolytic anemia (wAIHA).

Learn more

M254 ITP Study

Hyper-sialylated IgG M254, an innovative therapeutic candidate, being evaluated in healthy volunteers and patients with immune thrombocytopenia purpura (ITP).

Learn more